578 related articles for article (PubMed ID: 26768192)
1. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
6. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
[TBL] [Abstract][Full Text] [Related]
7. Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
Yamashita H; Ashida K; Fukuchi T; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Ito D
J Smooth Muscle Res; 2012; 48(5-6):125-35. PubMed ID: 23538509
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
Tong S; Mallitt KA; Krishnan U
Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
[TBL] [Abstract][Full Text] [Related]
9. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.
Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A
Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273
[TBL] [Abstract][Full Text] [Related]
10. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Furnari M; Martinucci I; Mirante VG; Marchi S; Savarino V; Savarino E
Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27620303
[TBL] [Abstract][Full Text] [Related]
11. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
12. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
13. Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
Matsumura T; Sonoda M; Okimoto K; Dao HV; Takahashi S; Akizue N; Horio R; Goto C; Kurosugi A; Kaneko T; Ohta Y; Taida T; Kikuchi A; Fujie M; Kato J; Kato N
Dig Dis Sci; 2024 Jun; 69(6):2132-2139. PubMed ID: 38622462
[TBL] [Abstract][Full Text] [Related]
14. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
15. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
[TBL] [Abstract][Full Text] [Related]
16. Impedance-high resolution manometry analysis of patients with nonerosive reflux disease.
Ribolsi M; Holloway RH; Emerenziani S; Balestrieri P; Cicala M
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):52-7. PubMed ID: 23891920
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with nonresponse to proton pump inhibitors therapy in patients referred for esophageal pH-impedance monitoring.
Garros A; Mion F; Marjoux S; Damon H; Roman S
Dis Esophagus; 2016 Oct; 29(7):787-793. PubMed ID: 25951923
[TBL] [Abstract][Full Text] [Related]
18. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD.
Tolone S; de Cassan C; de Bortoli N; Roman S; Galeazzi F; Salvador R; Marabotto E; Furnari M; Zentilin P; Marchi S; Bardini R; Sturniolo GC; Savarino V; Savarino E
Neurogastroenterol Motil; 2015 Aug; 27(8):1175-82. PubMed ID: 26010058
[TBL] [Abstract][Full Text] [Related]
19. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring.
Xiao Y; Liang M; Peng S; Zhang N; Chen M
J Gastroenterol Hepatol; 2016 Feb; 31(2):350-4. PubMed ID: 26202002
[TBL] [Abstract][Full Text] [Related]
20. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
